Sort
15,440 grants matching “organoids”
Combating Resistance of Pancreatic Cancer with a First-in-Class Dual Targeted PI3K/EGFR Inhibitor
$484,410Judith S Leopold · University Of Michigan At Ann Arbor · R01 · FY2019 · CA
Combating Resistance of Pancreatic Cancer with a First-in-Class Dual Targeted PI3K/EGFR Inhibitor
$484,410Judith S Leopold · University Of Michigan At Ann Arbor · R01 · FY2021 · CA
Targeting a Novel Signaling Nexus pACK/pCSK/pLCK in Immune Checkpoint Blockade (ICB)-Resistant Prostate Cancer
$484,365Nupam P Mahajan · Washington University · R01 · FY2025 · CA
Targeting a Novel Signaling Nexus pACK/pCSK/pLCK in Immune Checkpoint Blockade (ICB)-Resistant Prostate Cancer
$484,364Nupam P Mahajan · Washington University · R01 · FY2023 · CA
Novel approach of targeting AT-rich S/MAR regions for treating therapy resistant breast cancers
$484,169Manjeet Kumar Rao · University Of Texas Hlth Science Center · R01 · FY2025 · CA
Novel approach of targeting AT-rich S/MAR regions for treating therapy resistant breast cancers
$484,169Manjeet Kumar Rao · University Of Texas Hlth Science Center · R01 · FY2023 · CA
Ferroptosis and Ferroptotic Stress in Maladaptive Renal Repair
$484,168Tomokazu Souma · Duke University · R01 · FY2024 · DK
Montreal-Boston Collaborative GRC
$484,091John D. Rioux · Montreal Heart Institute · U01 · FY2025 · DK
Polymerase epsilon-based mouse and derived organoid models of intestinal cancer
$484,055Diego H Castrillon · Ut Southwestern Medical Center · R01 · FY2023 · CA
Intestinal O-GlcNAc signaling and mucosal host defense
$483,958Hai-Bin Ruan · University Of Minnesota · R56 · FY2021 · AI
Biological Basis of Phenotypes and Clinical Outcomes in Biliary Atresia
$483,857Jorge A. Bezerra · Ut Southwestern Medical Center · R01 · FY2023 · DK
Research Project 3: Optimizing DNA damage repair-targeted combination therapy
$483,811Funda Meric-Bernstam · University Of Tx Md Anderson Can Ctr · U54 · FY2017 · CA
Project 2: Building Combinatorial Therapies against KRAS-mutant Colorectal and Pancreatic Cancer
$483,810Jason B Fleming · University Of Tx Md Anderson Can Ctr · U54 · FY2017 · CA
Neuroprotective Mechanisms of S-Nitrosylated ApoE2 in Aging and Alzheimer's Disease
$483,750Tomohiro Nakamura · Scripps Research Institute, The · R01 · FY2019 · AG
Neuroprotective Mechanisms of S-Nitrosylated ApoE2 in Aging and Alzheimer's Disease
$483,750Tomohiro Nakamura · Scripps Research Institute, The · R01 · FY2018 · AG
Neuroprotective Mechanisms of S-Nitrosylated ApoE2 in Aging and Alzheimer's Disease
$483,750Tomohiro Nakamura · Scripps Research Institute, The · R01 · FY2021 · AG
Neuroprotective Mechanisms of S-Nitrosylated ApoE2 in Aging and Alzheimer's Disease
$483,750Tomohiro Nakamura · Scripps Research Institute, The · R01 · FY2020 · AG
Neuroprotective Mechanisms of S-Nitrosylated ApoE2 in Aging and Alzheimer's Disease
$483,750Tomohiro Nakamura · Scripps Research Institute, The · R01 · FY2022 · AG
Novel Proteomics Approach to HIV-Associated Neurocognitive Disorder & Drug Abuse
$483,750Stuart A Lipton · Scripps Research Institute, The · DP1 · FY2019 · DA
Improving the translational value of head and neck cancer patient-in-mouse models
$483,592Randall J Kimple · University Of Wisconsin-Madison · R37 · FY2024 · CA
Developing new therapeutic strategies for distinct Ras-driven cancers
$483,547Karen M Cichowski · Brigham And Women'S Hospital · R01 · FY2023 · CA
Addressing biological and therapeutic gaps in rare neuroendocrine cancer with a novel organoid-based model
$483,461Patricia Leal Dahia · University Of Texas Hlth Science Center · R01 · FY2022 · CA
Addressing biological and therapeutic gaps in rare neuroendocrine cancer with a novel organoid-based model
$483,461Patricia Leal Dahia · University Of Texas Hlth Science Center · R01 · FY2023 · CA
Project 1: Overcoming therapeutic resistance in pancreatic cancer through epigenetic reprogramming
$483,451Ronald M. Evans · Salk Institute For Biological Studies · P01 · FY2024 · CA
Montreal-Boston Collaborative GRC
$483,409John D. Rioux · Montreal Heart Institute · U01 · FY2023 · DK